However, most seemed to be dose-related, and were diminishing over the treatment time
Hypoglycemia Given that the aim of GLP-1RA therapy is mainly to reduce blood glucose levels, it is conceivable that these agents could cause hypoglycemia
Factors such as genetics, overall health, and the presence of other skin conditions can influence the severity of the reaction
The GLP-1 consumer over-indexes on food and beverage at about 9% higher than the non-user. Circana data shows 5.3% of consumers are actively embracing GLP-1s, and the number may rise to double-digits for those who have at least tried the drug, according to Lyons Wyatt
Its main weaknesses are pricing transparency and pharmacy disclosure, not its legitimacy or medication handling
Hypokalemia: All insulins, including Tresiba , cause a shift in potassium from the extracellular to intracellular space, possibly leading to hypokalemia